Research Advances and Clinical Impact of New Data From Crohn’s and Colitis Congress® 2021*

Download All
January 21-24, 2021; Virtual
Review expert commentary of key data from the 2021 virtual Crohn’s and Colitis Congress®
Anita Afzali, MD, MPH, FACG
Bruce E. Sands, MD, MS

New Data from the 2021 Virtual Crohn’s & Colitis Congress®

At the 2021 virtual congress, I was excited by select studies on emerging therapeutic approaches that remind us there is more to treating IBD than suppressing the immune system.

Bruce E. Sands, MD, MS Released: March 1, 2021

In this commentary, I present my take on interesting new data from the 2021 virtual Crohn’s & Colitis Congress on the relationship between visceral adipose tissue and outcomes for patients with IBD and the role of diet in IBD management.

Anita Afzali, MD, MPH, FACG Released: March 5, 2021
Provided by Clinical Care Options.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AbbVie

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue